Mackenzie Financial Corp Reduces Johnson & Johnson Holdings

Investment firm trims stake in pharmaceutical giant by 0.2%

Mar. 11, 2026 at 10:51am

Got story updates? Submit your updates here. ›

Mackenzie Financial Corp, a major investment management firm, has reduced its holdings in Johnson & Johnson (NYSE:JNJ) by 0.2% during the third quarter, according to a recent 13F filing with the Securities and Exchange Commission. The firm now owns approximately 3.64 million shares of the pharmaceutical company, valued at around $675 million.

Why it matters

Johnson & Johnson is one of the world's largest and most diversified healthcare companies, with a significant presence in pharmaceuticals, medical devices, and consumer products. Changes in ownership by major institutional investors like Mackenzie Financial can provide insights into market sentiment and potential shifts in the stock's performance.

The details

According to the 13F filing, Mackenzie Financial sold 8,522 shares of Johnson & Johnson during the third quarter, reducing its total stake in the company to 3,641,918 shares. This represents approximately 0.15% of Johnson & Johnson's outstanding shares. The investment firm cited portfolio rebalancing and risk management as reasons for the modest reduction in its Johnson & Johnson holdings.

  • Mackenzie Financial Corp reduced its Johnson & Johnson holdings during the 3rd quarter of 2026.

The players

Mackenzie Financial Corp

A major Canadian investment management firm that oversees over $200 billion in assets.

Johnson & Johnson

A multinational pharmaceutical and consumer goods company headquartered in New Brunswick, New Jersey.

Got photos? Submit your photos here. ›

The takeaway

While Mackenzie Financial's reduction in Johnson & Johnson holdings is relatively small, it could signal a broader shift in investor sentiment towards the healthcare giant. Investors will likely continue to monitor changes in ownership by major institutional investors as an indicator of the stock's future performance.